Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogensin vitroandin vivo

Accelerating global innovation to address antibacterial resistance: introducing CARB-X

(2016) Kevin Outterson et al.   NATURE REVIEWS DRUG DISCOVERY

Novel Approaches Are Needed to Develop Tomorrow’s Antibacterial Therapies

(2015) Brad Spellberg et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: A nationwide multicenter study in Taiwan

(2015) Yea-Yuan Chang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Piscidin is Highly Active against Carbapenem-Resistant Acinetobacter baumannii and NDM-1-Producing Klebsiella pneumonia in a Systemic Septicaemia Infection Mouse Model

(2015) Chieh-Yu Pan et al.   Marine Drugs

AVI-7288 for Marburg Virus in Nonhuman Primates and Humans

(2015) Alison E. Heald et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies

(2014) Alison E. Heald et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance

(2014) Andrew M. King et al.   NATURE

Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria

(2014) Laurent Dortet et al.   Biomed Research International

Eteplirsen for the treatment of Duchenne muscular dystrophy

(2013) Jerry R. Mendell et al.   ANNALS OF NEUROLOGY

Blue-Carba, an Easy Biochemical Test for Detection of Diverse Carbapenemase Producers Directly from Bacterial Cultures

(2013) J. Pires et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Association of the Emerging Carbapenemase NDM-1 with a Bleomycin Resistance Protein in Enterobacteriaceae and Acinetobacter baumannii

(2012) Laurent Dortet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Outbreak of Carbapenem-Resistant Enterobacteriaceae at a Long-Term Acute Care Hospital: Sustained Reductions in Transmission through Active Surveillance and Targeted Interventions

(2012) Amit S. Chitnis et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

New Delhi Metallo-β-Lactamase: Structural Insights into β-Lactam Recognition and Inhibition

(2012) Dustin T. King et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention

(2011) M. J. Schwaber et al.   CLINICAL INFECTIOUS DISEASES

Persistent Carriage and Infection by Multidrug-Resistant Escherichia coli ST405 Producing NDM-1 Carbapenemase: Report on the First Italian Cases

(2011) Marco Maria D'Andrea et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: A matched case–control study

(2011) Hong-Jyun Chang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

The emerging NDM carbapenemases

(2011) Patrice Nordmann et al.   TRENDS IN MICROBIOLOGY

Three Decades of  -Lactamase Inhibitors

(2010) S. M. Drawz et al.   CLINICAL MICROBIOLOGY REVIEWS

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes

(2010) May Nguyen et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Emerging carbapenemases: a global perspective

(2010) Timothy R. Walsh   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antisense Phosphorodiamidate Morpholino Oligomers Targeted to an Essential Gene InhibitBurkholderia cepaciaComplex

(2010) David E. Greenberg et al.   JOURNAL OF INFECTIOUS DISEASES

Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India

(2009) D. Yong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

(2009) Abraham Borer et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo

(2008) B. L. Mellbye et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

(2008) Gopi Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Tackling antibiotic resistance: a dose of common antisense?

(2008) N. Woodford et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY